The European Innovation Council (EIC) has just awarded a €4.7M Pathfinder Grant to PAT4CGT Consortium for the Development of Modular Cell & Gene Therapy Manufacturing Platform. Swiss Biotech Limula will be the Technical Leader of the consortium composed of a multidisciplinary group of internationally recognized CGT experts and companies. The project will start in October 2022 and run for a period of 3 years.
